What is PLYX's current stock price?

PLYX (Polaryx Therapeutics, Inc. Common Stock) is currently trading at $3.60 with a market cap of $170.4M.

What sector is Polaryx Therapeutics, Inc. Common Stock in?

Polaryx Therapeutics, Inc. Common Stock (PLYX) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

PLYX Polaryx Therapeutics, Inc. Common Stock

Healthcare

$3.60-8.63%ClosedMarket Cap: $170.4M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

68.32

P/S

0.00

EV/EBITDA

-35.40

DCF Value

$0.10

FCF Yield

-2.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-166.1%

ROA

-185.0%

ROIC

-190.0%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$0.00	$-2.5M	$—
Q4 null	$0.00	$-1.5M	$—
FY null	$0.00	$-9.0M	$—
Q3 null	$0.00	$-1.4M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

1 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

0.00

Polaryx Therapeutics, Inc., operates as a biotech company that develops small molecule therapeutics for lysosomal storage disorders and neurodegenerative disorders. Its pipeline includes PLX-100, a combination of PLX-200 and a supplement for late infantile neuronal ceroid lipofuscinosis (LINCL) and other forms of NCL; PLX-200, a repurposed drug that is used to treat other diseases in adults and children; and PLX-300, a drug isolated from an edible plant that activates PPARa, which enhances production of transcription factor EB. The company was founded in 2014 and is based in Paramus, New Jersey.

Peers

KZR